Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel
Clinical trial NCT06538272 · COMPLETED
Trial details
- NCT number
- NCT06538272
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2024-09-19
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.